RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재후보

      지방합성 인자 조절 및 식이 섭취 감소를 통한 곽향의 항비만 효능 = Effects of Agastache rugosa on Obesity Via Inhibition of Peroxisome Proliferator-Activated Receptor-Gamma and Reduction of Food Intake

      한글로보기

      https://www.riss.kr/link?id=A104809447

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Objectives: The herb of Agastache rugosa (AR) is a traditional herbal medicine used for colds,vomiting and furuncles. However, there are few reports to investigate the inhibitory effects of ARon obesity. In this study, the effects of AR on high fat diet (HFD)-induced obesity and itsmechanism of actions were investigated in experimental animals.
      Methods: The mice were fed HFD for 4 weeks to induce obesity. After randomly divided intonormal fat diet, HFD and AR groups, 200 mg/kg of AR was administrated for 4 weeks withcontinuous HFD feeding while vehicle was orally treated to HFD group. Food intake and bodyweight were recorded weekly.
      Results: Increased body weight by HFD was improved by AR treatment. AR administrationinhibited an increase of visceral fat weight as well as adipocyte hypertrophy. Hepatic steatosiswas ameliorated in AR-treated mice. In addition, treatment of AR attenuated the expression ofadipogenic transcription factor, peroxisome proliferator-activated receptor (PPAR)-gamma in theepididymal adipose tissue. Also the increased serum leptin level by HFD was maintained in ARgroup, leading to inhibition of food intake.
      Conclusions: AR treatment showed inhibitory effects on HFD-induced obesity by inhibition ofPPAR-gamma and reduction of food intake. AR could be an alternative treatment for obesity.
      번역하기

      Objectives: The herb of Agastache rugosa (AR) is a traditional herbal medicine used for colds,vomiting and furuncles. However, there are few reports to investigate the inhibitory effects of ARon obesity. In this study, the effects of AR on high fat di...

      Objectives: The herb of Agastache rugosa (AR) is a traditional herbal medicine used for colds,vomiting and furuncles. However, there are few reports to investigate the inhibitory effects of ARon obesity. In this study, the effects of AR on high fat diet (HFD)-induced obesity and itsmechanism of actions were investigated in experimental animals.
      Methods: The mice were fed HFD for 4 weeks to induce obesity. After randomly divided intonormal fat diet, HFD and AR groups, 200 mg/kg of AR was administrated for 4 weeks withcontinuous HFD feeding while vehicle was orally treated to HFD group. Food intake and bodyweight were recorded weekly.
      Results: Increased body weight by HFD was improved by AR treatment. AR administrationinhibited an increase of visceral fat weight as well as adipocyte hypertrophy. Hepatic steatosiswas ameliorated in AR-treated mice. In addition, treatment of AR attenuated the expression ofadipogenic transcription factor, peroxisome proliferator-activated receptor (PPAR)-gamma in theepididymal adipose tissue. Also the increased serum leptin level by HFD was maintained in ARgroup, leading to inhibition of food intake.
      Conclusions: AR treatment showed inhibitory effects on HFD-induced obesity by inhibition ofPPAR-gamma and reduction of food intake. AR could be an alternative treatment for obesity.

      더보기

      참고문헌 (Reference)

      1 김주희, "지방전구세포와 고지방식이비만마우스에서 가미곽향정기산의 전탕액과 발효액의 항비만효과" 대한한방소아과학회 29 (29): 37-48, 2015

      2 강석용, "곽향(藿香)의 난알부민으로 유도된 천식 마우스에서의 천식개선 효능연구" 대한본초학회 30 (30): 1-12, 2015

      3 Foreyt J, "The ultimate triumph of obesity" 346 (346): 134-135, 1995

      4 Poulain M, "The effect of obesity on chronic respiratory diseases: pathophysiology and therapeutic strategies" 174 (174): 1293-1299, 2006

      5 Galobardes B, "The differential effect of education and occupation on body mass and overweight in a sample of working people of the general population" 10 (10): 532-537, 2000

      6 Hamilton MT, "Role of low energy expenditure and sitting in obesity, metabolic syndrome, type 2diabetes, and cardiovascular disease" 56 (56): 2655-2667, 2007

      7 Weigle DS, "Recombinant ob protein reduces feeding and body weight in the ob/ob mouse" 96 (96): 2065-2070, 1995

      8 Ogden CL, "Prevalence of childhood and adult obesity in the United States, 2011-2012" 311 (311): 806-814, 2014

      9 Yum K, "Orlistat (XenicalR)" 1 : 23-36, 2001

      10 Chua S, "Obesity genes: molecular and metabolic mechansims" 1 (1): 2-7, 1997

      1 김주희, "지방전구세포와 고지방식이비만마우스에서 가미곽향정기산의 전탕액과 발효액의 항비만효과" 대한한방소아과학회 29 (29): 37-48, 2015

      2 강석용, "곽향(藿香)의 난알부민으로 유도된 천식 마우스에서의 천식개선 효능연구" 대한본초학회 30 (30): 1-12, 2015

      3 Foreyt J, "The ultimate triumph of obesity" 346 (346): 134-135, 1995

      4 Poulain M, "The effect of obesity on chronic respiratory diseases: pathophysiology and therapeutic strategies" 174 (174): 1293-1299, 2006

      5 Galobardes B, "The differential effect of education and occupation on body mass and overweight in a sample of working people of the general population" 10 (10): 532-537, 2000

      6 Hamilton MT, "Role of low energy expenditure and sitting in obesity, metabolic syndrome, type 2diabetes, and cardiovascular disease" 56 (56): 2655-2667, 2007

      7 Weigle DS, "Recombinant ob protein reduces feeding and body weight in the ob/ob mouse" 96 (96): 2065-2070, 1995

      8 Ogden CL, "Prevalence of childhood and adult obesity in the United States, 2011-2012" 311 (311): 806-814, 2014

      9 Yum K, "Orlistat (XenicalR)" 1 : 23-36, 2001

      10 Chua S, "Obesity genes: molecular and metabolic mechansims" 1 (1): 2-7, 1997

      11 Kim TH, "Obesity and tatty liver disease" 68 (68): 347-349, 2005

      12 Dixon JB, "Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese" 121 (121): 91-100, 2001

      13 Yu AS, "Nonalcoholic fatty liver disease" 2 (2): 11-19, 2002

      14 Chitturi S, "NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome" 35 (35): 373-379, 2002

      15 Apfelbaum M, "Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine" 106 (106): 179-184, 1999

      16 Caro JF, "Leptin: the tale of an obesity gene" 45 (45): 1455-1462, 1996

      17 Elmquist JK, "Hypothalamic pathways underlying the endocrine, autonomic, and behavioral effects of leptin" 25 (25): S78-S82, 2001

      18 Esmaeili MA, "Hypoglycaemic effect of Teucrium polium: studies with rat pancreatic islets" 95 (95): 27-30, 2004

      19 Wanless IR, "Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors" 12 (12): 1106-1110, 1990

      20 Suleiman MS, "Effect of Teucrium polium boiled leaf extract on intestinal motility and blood pressure" 22 (22): 111-116, 1988

      21 Jones JR, "Deletion of PPARgamma in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance" 102 (102): 6207-6212, 2005

      22 "Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Expert panel on the identification, evaluation, and treatment of overweight in adults" 68 (68): 899-917, 1998

      23 Salah KB, "Chemical composition and in vitro antifungal and antioxidant activity of the essential oil and methanolic extract of Teucrium sauvagei Le Houerou" 20 (20): 1089-1097, 2006

      24 Flegal KM, "Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and metaanalysis" 309 (309): 71-82, 2013

      25 Shin D, "A clinical study on the effects of Gwakhyangjunggi-san gamibag on 9 obese children" 15 (15): 183-194, 2001

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2028 평가예정 재인증평가 신청대상 (재인증)
      2022-01-01 평가 등재학술지 유지 (재인증) KCI등재
      2019-01-01 평가 등재학술지 유지 (계속평가) KCI등재
      2016-01-01 평가 등재학술지 선정 (계속평가) KCI등재
      2014-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      2012-01-01 평가 등재후보 탈락 (기타)
      2010-01-01 평가 등재후보 1차 FAIL (등재후보1차) KCI등재후보
      2008-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.48 0.48 0.85
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.88 0.89 1.299 0.18
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼